The S&P 1500 Health Care Index advanced 4.0% in the third quarter, underperforming the S&P 500, which gained 8.1%. Read more ...

One lingering challenge is the 777X program, which has been delayed again and is now expected to enter service in ...

Create your free account and save 20% sitewide with our Black Friday sale. Access expert insights, powerful tools, and ...

OBDC trades at a deep discount with strong credit quality, growing assets, low non-accruals, and a double-digit yield. Learn ...

Read here for wealth-building strategies for every age: maximize compounding in your 20s, focus on growth, then shift to ...

Oakmark Japan Strategy portfolio’s return was 4.93% (Net) for the reporting period versus MSCI Japan Index (Net) that ...

Covered call ETFs surge with AI-heavy indices, stretched valuations, correction risks, and rising economic pressure on KLAR ...

Blue Owl Capital trades 20% below NAV with strong fundamentals, 91.7% performing assets, 12.4% yield, and $200M buyback. See ...

IREN shifts from bitcoin mining to AI compute with a $10B Microsoft deal boosting ARR and trading at 4.6x 2026/2027 sales.

Kadant trades at 27x earnings with revenue declines, a subdued outlook, an accretive Clyde deal, and low-growth industry ...

Krystal Biotech drives Vyjuvek growth, premium margins, global expansion, a $1B goal, and pipeline data ahead with a $219.50 ...

Marcus Corporation (MCS) remains a 'Buy' with +35% upside potential as real estate assets and shareholder returns support ...